ACTA GASTRO-ENTEROLOGICA BELGICA, vol.76, no.1, pp.34-37, 2013 (SCI-Expanded)
Background/Aims : Bismuth-containing quadruple therapy given four times a day is effective in the first-line treatment of Helicobacter pylori. We aimed to investigate whether twice daily posology could eradicate H. pylori at a comparable rate in an area with a high prevalence of antibiotic resistance.